Tandem Diabetes Care Has Run Up A Lot - Cramer's Lightning Round (6/15/18)
Seeking Alpha Tandem Diabetes Care (NASDAQ:TNDM): The stock has run up a lot and Cramer thinks the profit has been made. Altria Group (NYSE:MO) : "I think it is not a buy. I don't even know if I want to hold it here because there are technical challenges now that ... Tandem Diabetes Care (TNDM) PT Raised to $24 at Oppenheimer; 'Shares Still at Discount with Catalysts Ahead' Can These Stocks Continue To Spark? – iQIYI, Inc. (IQ), Tandem Diabetes Care, Inc. (TNDM) |
from diabetes - Google News
Social Plugin